A clinical-grade serum-free high-efficiency expansion medium for UNKT cells, its preparation method and application
By designing a serum-free, high-efficiency amplification medium, the problems of insufficient UNKT cell amplification and safety hazards were solved, achieving efficient amplification and simplified culture of UNKT cells, which are suitable for clinical treatment.
Patent Information
- Application Number
- CN202611533111.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-30
- Publication Date
- 2026-11-17
AI Technical Summary
The existing culture process results in insufficient expansion of UNKT cells, a low proportion, and potential safety risks. Furthermore, the use of animal-derived serum may introduce viruses and mycoplasma, failing to meet clinical treatment needs.
A serum-free, high-efficiency amplification medium was used, which included a basal medium and additives. The additives included rhIL-2, rhIL-15, rhIL-21, FK506, linoleic acid, folic acid, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, interleukin 15, etc. By adjusting the specific ratio and pH value, a serum-free, high-efficiency amplification medium for UNKT cells was formed.
This method achieves efficient expansion of UNKT cells, reduces the risk of contamination, promotes the activation and large-scale expansion of UNKT cells, simplifies the culture process, reduces costs, and is suitable for clinical treatment.
Abstract
Description
Technical Field
[0001] This invention relates to the field of cell culture technology, and in particular to a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, its preparation method, and its application. Background Technology
[0002] UNKT cells possess key characteristics of both T cells and NK cells (natural killer cells): they express both T cell surface markers, CD3 and NK cell surface marker CD56. This allows them to accurately identify targets like T cells and rapidly attack like NK cells. They exhibit potent tumor-killing capabilities, high safety, and excellent tumor penetration.
[0003] Existing culture processes involve the addition of animal-derived serum, which may introduce exogenous viruses and mycoplasma, posing certain safety risks. The tumor cells used in the culture methods also present certain safety issues. Furthermore, the number of UNKT cells cultured using existing methods is insufficient, resulting in a low proportion of UNKT cells, which cannot meet the needs of clinical treatment. Summary of the Invention
[0004] The technical problem to be solved by the present invention is to provide a clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells and its preparation method to solve the above-mentioned problem.
[0005] To solve the above-mentioned technical problems, the technical solution adopted by the present invention is: a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, wherein the medium comprises a basal medium and additive components, and the volume ratio of the basal medium to the additive components is 48:(1-2); the additive components include rhIL-2 5-16 ng / mL, rhIL-15 10-60 ng / mL, rhIL-2 14-12 ng / mL, FK506 8-40 ng / mL, linoleic acid 300-1000 mg / L, folic acid 2.15-2.45 mg / L, recombinant human insulin 2-12 µg / mL, recombinant deferferrin 1-8 µg / mL, recombinant human serum albumin 2-5 mg / mL, interleukin 2 15-45 mg / L, and interleukin 15 20-60 mg / L.
[0006] As a further embodiment of the present invention, the added components also include phosphatidylcholine 20-40 IU / ml and gentamicin 18-38 IU / ml.
[0007] As a further embodiment of the present invention, the basal culture medium is IMDM medium and DMEM / F12 medium, and the ratio of IMDM medium to DMEM / F12 medium is 1:(1-1.5).
[0008] As a further aspect of the present invention, the pH of the culture medium is 7.0-7.5.
[0009] As a further embodiment of the present invention, the added components also include amino acids, vitamins and inorganic salts, wherein the ratio of amino acids, vitamins and inorganic salts is 1:(60-80):(140-160).
[0010] As a further embodiment of the present invention, the concentrations of each component of the amino acids are as follows: glycine 20-30 mg / L, L-arginine 60-70 mg / L, and L-histidine 25-40 mg / L.
[0011] As a further embodiment of the present invention, the concentrations of each component of the vitamins are as follows: biotin 0.1-0.3 mg / L, D-calcium pantothenate 1-3 mg / L, riboflavin 0.5-2.5 mg / L, inositol 4-8 mg / L, and vitamin B3-5 mg / L.
[0012] As a further embodiment of the present invention, the concentrations of each component of the inorganic salts are as follows: calcium nitrate 115-135 mg / L, anhydrous magnesium sulfate 85-100 mg / L, potassium chloride 240-280 mg / L, and potassium nitrate 0.05-1 mg / L.
[0013] A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells, the specific steps of which are as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
[0014] Application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, wherein the medium is used to culture UNKT cells.
[0015] Because the present invention adopts the above technical solution, the advantages and positive effects of the present invention are: avoiding the introduction of exogenous substances and reducing the risk of pollution; at the same time, multiple cytokines can stimulate UNKT cells with signals, activate UNKT cells, and promote their large-scale expansion; the cell culture method provided by the present invention is simple, efficient, low-cost, and can expand high-purity UNKT cells in a short period of time, which is of great importance for clinical treatment. Detailed Implementation Example
[0016] This invention discloses a clinical-grade serum-free high-efficiency expansion medium for UNKT cells. The medium comprises a basal medium and supplementary components, with a volume ratio of basal medium to supplementary components of 48:1. The supplementary components include rhIL-25 ng / mL, rhIL-15 10 ng / mL, rhIL-21 4 ng / mL, FK506 8 ng / mL, linoleic acid 300 mg / L, folic acid 2.15 mg / L, recombinant human insulin 2 µg / mL, recombinant deferferrin 1 µg / mL, recombinant human serum albumin 2 mg / mL, interleukin 215 mg / L, and interleukin-15... The basal culture medium, containing 20 mg / L phosphatidylcholine, 20 IU / ml phosphatidylcholine, and 18 IU / ml gentamicin, consisted of IMDM and DMEM / F12 media in a 1:1 ratio. The added components also included amino acids, vitamins, and inorganic salts in a 1:60:140 ratio. The concentrations of the amino acid components were: glycine 20 mg / L, L-arginine 60 mg / L, and L-histidine 25 mg / L. The concentrations of the vitamin components were: biotin 0.1 mg / L, D-calcium pantothenate 1 mg / L, riboflavin 0.5 mg / L, inositol 4.0 mg / L, and vitamin B3 3 mg / L. The concentrations of the inorganic salt components were: calcium nitrate 115 mg / L, anhydrous magnesium sulfate 85 mg / L, potassium chloride 240 mg / L, and potassium nitrate 0.05 mg / L. The pH of the culture medium was 7.0.
[0017] A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells, the specific steps of which are as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
[0018] Application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, characterized in that: the medium is used to culture UNKT cells. Example
[0019] This invention discloses a clinical-grade serum-free high-efficiency expansion medium for UNKT cells. The medium comprises a basal medium and supplementary components, with a volume ratio of basal medium to supplementary components of 48:1.4. The supplementary components include rhIL-2 8 ng / mL, rhIL-15 25 ng / mL, rhIL-21 7 ng / mL, FK506 17 ng / mL, linoleic acid 550 mg / L, folic acid 2.25 mg / L, recombinant human insulin 6 µg / mL, recombinant deferferrin 3 µg / mL, recombinant human serum albumin 3 mg / mL, interleukin-2 25 mg / L, and interleukin-15... 30 mg / L, phosphatidylcholine 25 IU / ml, gentamicin 25 IU / ml; the basal culture medium was IMDM medium and DMEM / F12 medium in a ratio of 1:1.2. The added components also included amino acids, vitamins, and inorganic salts in a ratio of 1:65:145. The concentrations of each amino acid component were: glycine 23 mg / L, L-arginine 64 mg / L, L-histidine 30 mg / L; the concentrations of each vitamin component were: biotin 0.18 mg / L, D-calcium pantothenate 1.5 mg / L, riboflavin 1 mg / L, inositol 5 mg / L, vitamin B... The concentrations of the inorganic salts were 3.5 mg / L: calcium nitrate 120 mg / L, anhydrous magnesium sulfate 90 mg / L, potassium chloride 250 mg / L, and potassium nitrate 0.22 mg / L; the pH of the culture medium was 7.2.
[0020] A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells, the specific steps of which are as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
[0021] Application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, wherein the medium is used to culture UNKT cells. Example
[0022] This invention discloses a clinical-grade serum-free high-efficiency expansion medium for UNKT cells. The medium comprises a basal medium and supplementary components, with a volume ratio of basal medium to supplementary components of 48:1.6. The supplementary components include rhIL-21 3 ng / mL, rhIL-15 45 ng / mL, rhIL-21 10 ng / mL, FK506 30 ng / mL, linoleic acid 800 mg / L, folic acid 2.35 mg / L, recombinant human insulin 10 µg / mL, recombinant deferferrin 6 µg / mL, recombinant human serum albumin 4 mg / mL, interleukin-2 35 mg / L, and interleukin-15... 50 mg / L, phosphatidylcholine 35 IU / ml, gentamicin 32 IU / ml; the basal culture medium was IMDM medium and DMEM / F12 medium in a ratio of 1:1.4. The added components also included amino acids, vitamins, and inorganic salts in a ratio of 1:72:154. The concentrations of each amino acid component were: glycine 27 mg / L, L-arginine 66 mg / L, L-histidine 33 mg / L; the concentrations of each vitamin component were: biotin 0.24 mg / L, D-calcium pantothenate 2.5 mg / L, riboflavin 2 mg / L, inositol 7 mg / L, and vitamin B12 32 mg / L. The concentrations of the inorganic salts were 4.5 mg / L, and the concentrations of each component were: calcium nitrate 130 mg / L, anhydrous magnesium sulfate 95 mg / L, potassium chloride 270 mg / L, and potassium nitrate 0.6 mg / L; the pH of the culture medium was 7.4.
[0023] A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells, the specific steps of which are as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
[0024] Application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, wherein the medium is used to culture UNKT cells. Example
[0025] This invention discloses a clinical-grade serum-free high-efficiency expansion medium for UNKT cells. The medium comprises a basal medium and supplementary components, with a volume ratio of basal medium to supplementary components of 24:1. The supplementary components include rhIL-2 16 ng / mL, rhIL-15 60 ng / mL, rhIL-21 12 ng / mL, FK506 40 ng / mL, linoleic acid 1000 mg / L, folic acid 2.45 mg / L, recombinant human insulin 12 µg / mL, recombinant deferferrin 8 µg / mL, recombinant human serum albumin 5 mg / mL, interleukin-2 45 mg / L, interleukin-15 60 mg / L, and further include phosphatidylcholine 40 IU / mL and gentamicin 38 IU / mL. The basal medium is a mixture of IMDM and DMEM / F12 media, with a ratio of IMDM to DMEM / F12 media of 1:1.5. The added components also include amino acids, vitamins, and inorganic salts, with a ratio of 1:80:160. The concentrations of each component of the amino acids are as follows: glycine 30 mg / L, L-arginine 70 mg / L, and L-histidine 40 mg / L. The concentrations of each component of the vitamins are as follows: biotin 0.3 mg / L, D-calcium pantothenate 3 mg / L, riboflavin 2.5 mg / L, inositol 8 mg / L, and vitamin B 5 mg / L. The concentrations of each component of the inorganic salts are as follows: calcium nitrate 135 mg / L, anhydrous magnesium sulfate 100 mg / L, potassium chloride 280 mg / L, and potassium nitrate 1 mg / L. The pH of the culture medium is 7.5.
[0026] A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells, the specific steps of which are as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
[0027] Application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells, wherein the medium is used to culture UNKT cells.
[0028] While specific embodiments of the present invention have been described above, those skilled in the art should understand that these are merely illustrative examples, and various changes or modifications can be made to these embodiments without departing from the principles and essence of the present invention. The scope of protection of the present invention is defined only by the appended claims.
Claims
1. A clinical-grade serum-free, high-efficiency expansion medium for UNKT cells, characterized by: The culture medium comprises a basal medium and supplementary components, wherein the volume ratio of the basal medium to the supplementary components is 48:(1-2); the supplementary components include rhIL-2 5-16 ng / mL, rhIL-15 10-60 ng / mL, rhIL-21 4-12 ng / mL, FK506 8-40 ng / mL, linoleic acid 300-1000 mg / L, folic acid 2.15-2.45 mg / L, recombinant human insulin 2-12 µg / mL, recombinant deferferrin 1-8 µg / mL, recombinant human serum albumin 2-5 mg / mL, interleukin 2 15-45 mg / L, and interleukin 15 20-60 mg / L.
2. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 1, characterized in that: The added components also include phosphatidylcholine 20-40 IU / ml and gentamicin 18-38 IU / ml.
3. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 1, characterized in that: The basal culture medium is IMDM medium and DMEM / F12 medium, and the ratio of IMDM medium to DMEM / F12 medium is 1:(1-1.5).
4. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 1, characterized in that: The pH of the culture medium is 7.0-7.
5.
5. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 1, characterized in that: The added components also include amino acids, vitamins and inorganic salts, and the ratio of amino acids, vitamins and inorganic salts is 1:(60-80):(140-160).
6. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 5, characterized in that: The concentrations of each component of the amino acids are as follows: glycine 20-30 mg / L, L-arginine 60-70 mg / L, and L-histidine 25-40 mg / L.
7. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 5, characterized in that: The concentrations of each component of the vitamins are as follows: biotin 0.1-0.3 mg / L, D-calcium pantothenate 1-3 mg / L, riboflavin 0.5-2.5 mg / L, inositol 4-8 mg / L, and vitamin B3-5 mg / L.
8. The clinical-grade serum-free high-efficiency expansion culture medium for UNKT cells according to claim 5, characterized in that: The concentrations of each component of the inorganic salts are as follows: calcium nitrate 115-135 mg / L, anhydrous magnesium sulfate 85-100 mg / L, potassium chloride 240-280 mg / L, and potassium nitrate 0.05-1 mg / L.
9. A method for preparing a serum-free, high-efficiency expansion medium for clinical-grade UNKT cells according to any one of claims 1-8, characterized in that: Specific steps as follows: Step 1: Dissolve rhIL-2, rhIL-15, rhIL-21, FK506, recombinant human insulin, recombinant deferferrin, recombinant human serum albumin, interleukin 2, and interleukin 15 in basal culture medium without sodium bicarbonate to form the first solution. Step 2: Dissolve linoleic acid, folic acid, amino acids, vitamins and inorganic salts in anhydrous ethanol to form a second solution; Step 3: Mix the first solution and the second solution with phosphatidylcholine and gentamicin, and then dilute with basal culture medium to form a serum-free high-efficiency amplification medium for UNKT cells.
10. An application of a clinical-grade serum-free high-efficiency expansion medium for UNKT cells according to any one of claims 1-8, characterized in that: The culture medium is used to culture UNKT cells.
